Why is Aurobindo Pharma falling/rising?

As of 03-Jul, Aurobindo Pharma Ltd. is experiencing a slight increase in its stock price, currently at 1,159.00, reflecting a change of 1.25 (0.11%) upwards. The stock has shown a positive trend recently, gaining 2.34% over the last two days, although it underperformed its sector by 0.37% today. In terms of returns, the stock has increased by 3.04% over the past week, while it has underperformed over the past month with a gain of only 1.17%. Despite a year-to-date decline of 13.20%, the company maintains a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2.1, which may support investor confidence. Additionally, high institutional holdings at 41.57% suggest that knowledgeable investors are backing the stock, which could positively influence its price movement.
In the broader market context, Aurobindo Pharma's recent short-term performance contrasts with the Sensex, which has declined by 0.62% over the past week. While the stock has shown resilience in the short term, its year-to-date performance remains significantly lower than the Sensex's gain of 6.53%. The stock's liquidity is also favorable, with a delivery volume increase of 22.85% compared to the five-day average, indicating rising investor participation. Overall, while the stock is currently rising, it faces challenges in the longer term, as evidenced by its negative returns over the past year and year-to-date compared to the benchmark.